Journal of Cell Science, Vol 104, Issue 1 69-76, Copyright © 1993 by Company of Biologists

JOURNAL ARTICLES

Tenascin expression in the mouse: in situ localization and induction in vitro by bFGF

RP Tucker, JA Hammarback, DA Jenrath, EJ Mackie and Y Xu
Department of Neurobiology and Anatomy, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, North Carolina 27157-1010.

The glycoprotein tenascin is found in the extracellular matrix in regions of cell motility, cell proliferation, and tissue modelling. We have used novel tenascin cDNA probes to localize tenascin transcripts in the developing mouse and to study the regulation of tenascin expression by growth factors in vitro. At postnatal day 1 tenascin mRNAs are abundant in regions of bone and cartilage formation, as well as in the ependymal layer of the central nervous system. Previous studies have demonstrated that transforming growth factor-beta type 1 (TGF-beta 1) can induce tenascin expression in vitro. As TGF-beta 1 is absent or scarce in the developing brain, it is likely that other growth factors, alone or in addition to TGF-beta 1, may regulate tenascin expression during development. Therefore, we have compared the effects of TGF-beta 1 and a growth factor that is found in both developing connective tissue and the central nervous system, basic fibroblast growth factor (bFGF), on tenascin expression in a mouse embryo fibroblast cell line (Swiss 3T3 cells). Immuno-slot blot analysis of Swiss 3T3 cell-conditioned culture medium demonstrates that bFGF is a more potent inducer of tenascin expression than TGF-beta 1. Furthermore, bFGF and TGF-beta 1 have an additive effect on levels of tenascin, but not fibronectin, in the conditioned medium. Western blots revealed that different forms of tenascin are induced by bFGF and TGF-beta 1: the tenascin induced by the former has a molecular mass of approximately 250 kDa, the latter induces an approximately 200 kDa form of tenascin. The induction of large tenascin by bFGF was confirmed by northern blot analysis, which revealed increased levels of an 8 kb tenascin transcript after 24 h by as little as 4 ng/ml of bFGF in serum-free medium. Thus bFGF, alone or in combination with TGF-beta 1, is a potential regulator of tenascin expression in vitro. bFGF may alter not only the relative abundance of tenascin and fibronectin in the extracellular matrix, but also the splice variant of tenascin expressed by a given cell type.

This article has been cited by other articles:

				M. Fluck, M. Chiquet, S. Schmutz, M.-H. Mayet-Sornay, and D. Desplanches Reloading of atrophied rat soleus muscle induces tenascin-C expression around damaged muscle fibers Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2003; 284(3): R792 - R801. [Abstract] [Full Text] [PDF]

				R. Castellon, S. Caballero, H. K. Hamdi, S. R. Atilano, A. M. Aoki, R. W. Tarnuzzer, M. C. Kenney, M. B. Grant, and A. V. Ljubimov Effects of Tenascin-C on Normal and Diabetic Retinal Endothelial Cells in Culture Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2758 - 2766. [Abstract] [Full Text] [PDF]

				D. Zagzag, B. Shiff, G. I. Jallo, M. A. Greco, C. Blanco, H. Cohen, J. Hukin, J. C. Allen, and D. R. Friedlander Tenascin-C Promotes Microvascular Cell Migration and Phosphorylation of Focal Adhesion Kinase Cancer Res., May 1, 2002; 62(9): 2660 - 2668. [Abstract] [Full Text] [PDF]

				S. Akhtar, A. J Bron, N. R Hawksworth, R. E Bonshek, and K. M Meek Ultrastructural morphology and expression of proteoglycans, {beta}ig-h3, tenascin-C, fibrillin-1, and fibronectin in bullous keratopathy Br. J. Ophthalmol., June 1, 2001; 85(6): 720 - 731. [Abstract] [Full Text] [PDF]

				L. Häkkinen, H. C. Hildebrand, A. Berndt, H. Kosmehl, and H. Larjava Immunolocalization of Tenascin-C, {alpha}9 Integrin Subunit, and {alpha}v{beta}6 Integrin During Wound Healing in Human Oral Mucosa J. Histochem. Cytochem., July 1, 2000; 48(7): 985 - 998. [Abstract] [Full Text]

				M. Alizadeh, C. M. Gelfman, S. R. Bench, and L. M. Hjelmeland Expression and Splicing of FGF Receptor mRNAs during APRE-19 Cell Differentiation In Vitro Invest. Ophthalmol. Vis. Sci., July 1, 2000; 41(8): 2357 - 2362. [Abstract] [Full Text]

				S. Schenk, R. Chiquet-Ehrismann, and E. J. Battegay The Fibrinogen Globe of Tenascin-C Promotes Basic Fibroblast Growth Factor-induced Endothelial Cell Elongation Mol. Biol. Cell, September 1, 1999; 10(9): 2933 - 2943. [Abstract] [Full Text]

				A. Joester and A. Faissner Evidence for Combinatorial Variability of Tenascin-C Isoforms and Developmental Regulation in the Mouse Central Nervous System J. Biol. Chem., June 11, 1999; 274(24): 17144 - 17151. [Abstract] [Full Text] [PDF]

				T. Jarvinen, L Jozsa, P Kannus, T. Jarvinen, M Kvist, T Hurme, J Isola, H Kalimo, and M Jarvinen Mechanical loading regulates tenascin-C expression in the osteotendinous junction J. Cell Sci., January 9, 1999; 112(18): 3157 - 3166. [Abstract] [PDF]

				Y. T Konttinen, T.-F. Li, O. Michelsson, J.-W. Xu, T. Sorsa, S. Santavirta, S. Imai, and I. Virtanen Expression of tenascin-C in aseptic loosening of total hip replacement Ann Rheum Dis, October 1, 1998; 57(10): 619 - 623. [Abstract] [Full Text]

				G. M. Smith and J. H. Hale Macrophage/Microglia Regulation of Astrocytic Tenascin: Synergistic Action of Transforming Growth Factor-beta and Basic Fibroblast Growth Factor J. Neurosci., December 15, 1997; 17(24): 9624 - 9633. [Abstract] [Full Text] [PDF]

				F. Wempe, V. Lindner, and H. G. Augustin Basic Fibroblast Growth Factor (bFGF) Regulates the Expression of the CC Chemokine Monocyte Chemoattractant Protein-1 (MCP-1) in Autocrine-Activated Endothelial Cells Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2471 - 2478. [Abstract] [Full Text]

				P. L. Jones and M. Rabinovitch Tenascin-C Is Induced With Progressive Pulmonary Vascular Disease in Rats and Is Functionally Related to Increased Smooth Muscle Cell Proliferation Circ. Res., December 1, 1996; 79(6): 1131 - 1142. [Abstract] [Full Text]

				T Sakai, Y Furukawa, R Chiquet-Ehrismann, M Nakamura, S Kitagawa, T Ikemura, and K Matsumoto Tenascin-X expression in tumor cells and fibroblasts: glucocorticoids as negative regulators in fibroblasts J. Cell Sci., January 8, 1996; 109(8): 2069 - 2077. [Abstract] [PDF]

				A. Siri, V. Knäuper, N. Veirana, F. Caocci, G. Murphy, and L. Zardi Different Susceptibility of Small and Large Human Tenascin-C Isoforms to Degradation by Matrix Metalloproteinases J. Biol. Chem., April 14, 1995; 270(15): 8650 - 8654. [Abstract] [Full Text] [PDF]

				L. Borsi, E. Balza, B. Gaggero, G. Allemanni, and L. Zardi The Alternative Splicing Pattern of the Tenascin-C Pre-mRNA Is Controlled by the Extracellular pH J. Biol. Chem., March 17, 1995; 270(11): 6243 - 6245. [Abstract] [Full Text] [PDF]

				J. Talts, A Weller, R Timpl, M Ekblom, and P Ekblom Regulation of mesenchymal extracellular matrix protein synthesis by transforming growth factor-beta and glucocorticoids in tumor stroma J. Cell Sci., January 6, 1995; 108(6): 2153 - 2162. [Abstract] [PDF]

				R Chammas, D Taverna, N Cella, C Santos, and N. Hynes Laminin and tenascin assembly and expression regulate HC11 mouse mammary cell differentiation J. Cell Sci., January 4, 1994; 107(4): 1031 - 1040. [Abstract] [PDF]

				R. Tucker, J Spring, S Baumgartner, D Martin, C Hagios, P. Poss, and R Chiquet-Ehrismann Novel tenascin variants with a distinctive pattern of expression in the avian embryo Development, January 3, 1994; 120(3): 637 - 647. [Abstract] [PDF]

				W. Rettig, H. Erickson, A. Albino, and P Garin-Chesa Induction of human tenascin (neuronectin) by growth factors and cytokines: cell type-specific signals and signalling pathways J. Cell Sci., January 2, 1994; 107(2): 487 - 497. [Abstract] [PDF]